Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
100+ Total results for product and free and sample content found
Citeline
27 Jun 2022
Following on from our review of trends in the current pharmaceutical R&D pipeline, this supplement takes a look at the industry’s success stories of 2021 – the drugs which were launched onto the market for the first time during the year.
Citeline
27 Jun 2022
Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.
Citeline
27 Jun 2022
As the COVID-19 pandemic stretched through a second year, its impacts continued to reshape the clinical trials landscape.
Topic Clinical Trials
Citeline
27 Jun 2022
As the world begins its transition into a post-pandemic existence, it becomes possible to look back on the past two years and begin to quantify the effects that COVID-19 has brought.
Topic Clinical Trials
By Ian Lloyd 17 Jun 2022
Authored for the last 25 years by Ian Lloyd, Senior Director of Pharmaprojects and Data Integration, this vital resource uses a music motif to turn up the volume on the evolution of trends in pharmaceutical R&D. Lloyd assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.
Topic Research & Development
Citeline Connect
16 Jun 2022
Accelerate study startup, drive engagement, and enable community and communication surrounding your clinical trials with Citeline Connect, the only end-to-end platform supporting all aspects of clinical trial recruitment.
TrialScope Disclose
16 Jun 2022
Europe’s new Clinical Trial Information System (CTIS), created by the European Medicines Agency (EMA), is due to be implemented in January 2022. Find out what sponsors must do to ensure compliance with this far-reaching new regulatory requirement.
Topic Clinical Trials
16 Jun 2022
Study feasibility is a fundamental contributor to the overall success of a clinical development program. However, selecting the right countries, sites and investigators and starting up as quickly as possible remains a challenge, leading to greatly variable performance and inaccurate predictions for important trial milestones.
Topic Clinical Trials
Citeline Study Feasibility
16 Jun 2022
This informative whitepaper introduces you to best practices in study feasibility, which laid the groundwork for our new predictive analytic that is launching soon, Citeline Study Feasibility. Our industry-leading technology will deliver advanced insight to improve your clinical trial decisions, fast-track enrollment and optimize cycle times – all with less effort.
Topic Clinical Trials
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
